

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.43171779 |
| 2 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.17514745 |
| 3 | cytidine deamination (GO:0009972) | 4.51581366 |
| 4 | cytidine metabolic process (GO:0046087) | 4.51581366 |
| 5 | cytidine catabolic process (GO:0006216) | 4.51581366 |
| 6 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.92206858 |
| 7 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.78964371 |
| 8 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.73714264 |
| 9 | proteasome assembly (GO:0043248) | 3.72589409 |
| 10 | base-excision repair, AP site formation (GO:0006285) | 3.71101031 |
| 11 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.63347068 |
| 12 | ATP synthesis coupled proton transport (GO:0015986) | 3.59769185 |
| 13 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.59769185 |
| 14 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.57786556 |
| 15 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.57786556 |
| 16 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.55333026 |
| 17 | actin nucleation (GO:0045010) | 3.49115484 |
| 18 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 3.45114925 |
| 19 | ribosomal small subunit assembly (GO:0000028) | 3.42601446 |
| 20 | iron-sulfur cluster assembly (GO:0016226) | 3.38418768 |
| 21 | metallo-sulfur cluster assembly (GO:0031163) | 3.38418768 |
| 22 | positive regulation of interleukin-17 production (GO:0032740) | 3.36137078 |
| 23 | negative regulation of mast cell activation (GO:0033004) | 3.35881034 |
| 24 | negative T cell selection (GO:0043383) | 3.31989608 |
| 25 | response to interferon-beta (GO:0035456) | 3.30658938 |
| 26 | regulation of chronic inflammatory response (GO:0002676) | 3.30339565 |
| 27 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.29494849 |
| 28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.28443938 |
| 29 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.28407635 |
| 30 | response to pheromone (GO:0019236) | 3.24550227 |
| 31 | regulation of regulatory T cell differentiation (GO:0045589) | 3.24480429 |
| 32 | mannosylation (GO:0097502) | 3.24106414 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.23644102 |
| 34 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.21886929 |
| 35 | mast cell activation (GO:0045576) | 3.20560740 |
| 36 | sequestering of actin monomers (GO:0042989) | 3.19746285 |
| 37 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.19480006 |
| 38 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.17360095 |
| 39 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.15813098 |
| 40 | negative regulation of T cell apoptotic process (GO:0070233) | 3.12327900 |
| 41 | positive T cell selection (GO:0043368) | 3.11385096 |
| 42 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.09744697 |
| 43 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.09744697 |
| 44 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.09744697 |
| 45 | positive regulation of defense response to virus by host (GO:0002230) | 3.08492023 |
| 46 | cellular response to interleukin-15 (GO:0071350) | 3.08433398 |
| 47 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.08338693 |
| 48 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.08338693 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.07340177 |
| 50 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.05117194 |
| 51 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.03530760 |
| 52 | S-adenosylmethionine metabolic process (GO:0046500) | 3.02791390 |
| 53 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.02430152 |
| 54 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.02303030 |
| 55 | sleep (GO:0030431) | 2.97974419 |
| 56 | positive thymic T cell selection (GO:0045059) | 2.97486839 |
| 57 | mast cell activation involved in immune response (GO:0002279) | 2.96767590 |
| 58 | mast cell degranulation (GO:0043303) | 2.96767590 |
| 59 | GPI anchor biosynthetic process (GO:0006506) | 2.96545571 |
| 60 | GPI anchor metabolic process (GO:0006505) | 2.94700221 |
| 61 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.94263992 |
| 62 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.94165959 |
| 63 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.93859002 |
| 64 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.93701578 |
| 65 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.92622412 |
| 66 | regulation of interleukin-8 secretion (GO:2000482) | 2.88893229 |
| 67 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.88215083 |
| 68 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.88215083 |
| 69 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.87596155 |
| 70 | platelet dense granule organization (GO:0060155) | 2.86317970 |
| 71 | ubiquinone biosynthetic process (GO:0006744) | 2.85732312 |
| 72 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.84364842 |
| 73 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.83318907 |
| 74 | regulation of activation of Janus kinase activity (GO:0010533) | 2.82268642 |
| 75 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.80469515 |
| 76 | positive regulation of cell killing (GO:0031343) | 2.77537714 |
| 77 | positive regulation of prostaglandin secretion (GO:0032308) | 2.76525900 |
| 78 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.74557397 |
| 79 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.74557397 |
| 80 | deoxyribonucleotide catabolic process (GO:0009264) | 2.74352925 |
| 81 | negative regulation of ligase activity (GO:0051352) | 2.74038931 |
| 82 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.74038931 |
| 83 | protein neddylation (GO:0045116) | 2.73893135 |
| 84 | regulation of natural killer cell differentiation (GO:0032823) | 2.72839760 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.72455610 |
| 86 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.71551461 |
| 87 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.71525864 |
| 88 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.70017546 |
| 89 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.69736990 |
| 90 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.68475244 |
| 91 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.67361692 |
| 92 | regulation of cell killing (GO:0031341) | 2.65461928 |
| 93 | kynurenine metabolic process (GO:0070189) | 2.64676827 |
| 94 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.63153063 |
| 95 | electron transport chain (GO:0022900) | 2.62885733 |
| 96 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.62308493 |
| 97 | positive regulation of B cell differentiation (GO:0045579) | 2.61783704 |
| 98 | piRNA metabolic process (GO:0034587) | 2.60052061 |
| 99 | respiratory electron transport chain (GO:0022904) | 2.60009578 |
| 100 | L-methionine biosynthetic process (GO:0071265) | 2.59941604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 4.07479897 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.72449924 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.54072583 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.29803746 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.21332017 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.12914169 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.11057254 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.00883147 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.90243386 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.73891593 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.65972172 |
| 12 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.61089877 |
| 13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.59855766 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.49959523 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.47403607 |
| 16 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.41444066 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.39790517 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.30172798 |
| 19 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.26258557 |
| 20 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.17185103 |
| 21 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.16171572 |
| 22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.12264569 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.10521320 |
| 24 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.95605674 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 1.93372601 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.93062222 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.82720038 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.75228747 |
| 29 | GATA3_26560356_Chip-Seq_TH2_Human | 1.75195512 |
| 30 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.63195069 |
| 31 | AR_20517297_ChIP-Seq_VCAP_Human | 1.60061502 |
| 32 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53879908 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51885987 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.50877605 |
| 35 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.46578826 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.46375960 |
| 37 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.46367801 |
| 38 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.45715301 |
| 39 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.45012268 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.44134510 |
| 41 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.39497393 |
| 42 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.39343424 |
| 43 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.39343424 |
| 44 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.36545806 |
| 45 | EWS_26573619_Chip-Seq_HEK293_Human | 1.36284859 |
| 46 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35666871 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35255505 |
| 48 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.31893130 |
| 49 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.31889000 |
| 50 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.31750294 |
| 51 | FUS_26573619_Chip-Seq_HEK293_Human | 1.24301515 |
| 52 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.23744213 |
| 53 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.23699240 |
| 54 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.22701368 |
| 55 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.21005773 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19953544 |
| 57 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.18059931 |
| 58 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.16589423 |
| 59 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16254374 |
| 60 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.15947276 |
| 61 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.15496439 |
| 62 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.14911952 |
| 63 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.14044366 |
| 64 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.11392814 |
| 65 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.11248930 |
| 66 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.09886038 |
| 67 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.09550099 |
| 68 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.09297479 |
| 69 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09297479 |
| 70 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.09176491 |
| 71 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09071211 |
| 72 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08119516 |
| 73 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.07706915 |
| 74 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.07706915 |
| 75 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.07002086 |
| 76 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.06534641 |
| 77 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04403223 |
| 78 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04319391 |
| 79 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.04029407 |
| 80 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.02554061 |
| 81 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.02203047 |
| 82 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01601860 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98012658 |
| 84 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.97369183 |
| 85 | P300_19829295_ChIP-Seq_ESCs_Human | 0.95243836 |
| 86 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.94970697 |
| 87 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94016100 |
| 88 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.93941322 |
| 89 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.93648529 |
| 90 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92291203 |
| 91 | MYB_26560356_Chip-Seq_TH1_Human | 0.92134918 |
| 92 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.92116849 |
| 93 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.91649402 |
| 94 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.91124508 |
| 95 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.91123344 |
| 96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90485163 |
| 97 | NCOR_22424771_ChIP-Seq_293T_Human | 0.90449161 |
| 98 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.90323985 |
| 99 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.89918648 |
| 100 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.89755091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.46612578 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.17468467 |
| 3 | MP0003763_abnormal_thymus_physiology | 2.81205646 |
| 4 | MP0009785_altered_susceptibility_to | 2.75969850 |
| 5 | MP0002102_abnormal_ear_morphology | 2.39643422 |
| 6 | MP0002166_altered_tumor_susceptibility | 2.33474878 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.30894962 |
| 8 | MP0000685_abnormal_immune_system | 2.26909624 |
| 9 | MP0003195_calcinosis | 2.21738066 |
| 10 | MP0003786_premature_aging | 2.14899751 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.11780818 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.11248952 |
| 13 | MP0001800_abnormal_humoral_immune | 2.06404078 |
| 14 | MP0006072_abnormal_retinal_apoptosis | 2.05696829 |
| 15 | MP0005075_abnormal_melanosome_morpholog | 2.02526926 |
| 16 | MP0003724_increased_susceptibility_to | 1.98715993 |
| 17 | MP0002006_tumorigenesis | 1.94306634 |
| 18 | MP0003011_delayed_dark_adaptation | 1.93853735 |
| 19 | MP0001873_stomach_inflammation | 1.89819097 |
| 20 | MP0002723_abnormal_immune_serum | 1.89203356 |
| 21 | MP0004147_increased_porphyrin_level | 1.88124512 |
| 22 | MP0008872_abnormal_physiological_respon | 1.80478013 |
| 23 | MP0001790_abnormal_immune_system | 1.70340551 |
| 24 | MP0005387_immune_system_phenotype | 1.70340551 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.69137860 |
| 26 | MP0001819_abnormal_immune_cell | 1.65363901 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.63996521 |
| 28 | MP0005084_abnormal_gallbladder_morpholo | 1.62910929 |
| 29 | MP0003252_abnormal_bile_duct | 1.61081155 |
| 30 | MP0000372_irregular_coat_pigmentation | 1.60423167 |
| 31 | MP0005025_abnormal_response_to | 1.59575669 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.56323322 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.54995703 |
| 34 | MP0001542_abnormal_bone_strength | 1.52764652 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.50864983 |
| 36 | MP0003646_muscle_fatigue | 1.50052912 |
| 37 | MP0001501_abnormal_sleep_pattern | 1.49551964 |
| 38 | MP0002933_joint_inflammation | 1.47952844 |
| 39 | MP0005360_urolithiasis | 1.46305232 |
| 40 | MP0002736_abnormal_nociception_after | 1.45510917 |
| 41 | MP0010386_abnormal_urinary_bladder | 1.42803046 |
| 42 | MP0003436_decreased_susceptibility_to | 1.41870645 |
| 43 | MP0002405_respiratory_system_inflammati | 1.41387647 |
| 44 | MP0005551_abnormal_eye_electrophysiolog | 1.35301649 |
| 45 | MP0002876_abnormal_thyroid_physiology | 1.30107181 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.28762065 |
| 47 | MP0006054_spinal_hemorrhage | 1.27727068 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.27515056 |
| 49 | MP0001968_abnormal_touch/_nociception | 1.26975470 |
| 50 | MP0000716_abnormal_immune_system | 1.26975090 |
| 51 | MP0002398_abnormal_bone_marrow | 1.26535843 |
| 52 | MP0003045_fibrosis | 1.24732015 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.22899097 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.22796525 |
| 55 | MP0008877_abnormal_DNA_methylation | 1.22293064 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.22247555 |
| 57 | MP0003866_abnormal_defecation | 1.22147068 |
| 58 | MP0005253_abnormal_eye_physiology | 1.21675704 |
| 59 | MP0002837_dystrophic_cardiac_calcinosis | 1.21574058 |
| 60 | MP0001764_abnormal_homeostasis | 1.21424529 |
| 61 | MP0001905_abnormal_dopamine_level | 1.17487720 |
| 62 | MP0008438_abnormal_cutaneous_collagen | 1.15867442 |
| 63 | MP0001919_abnormal_reproductive_system | 1.15611189 |
| 64 | MP0009764_decreased_sensitivity_to | 1.14547235 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.14423030 |
| 66 | MP0005389_reproductive_system_phenotype | 1.12218531 |
| 67 | MP0002722_abnormal_immune_system | 1.10096041 |
| 68 | MP0005410_abnormal_fertilization | 1.09343167 |
| 69 | MP0003950_abnormal_plasma_membrane | 1.08389882 |
| 70 | MP0003283_abnormal_digestive_organ | 1.07349173 |
| 71 | MP0001533_abnormal_skeleton_physiology | 1.07093299 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 1.06858587 |
| 73 | MP0001853_heart_inflammation | 1.06321320 |
| 74 | MP0002638_abnormal_pupillary_reflex | 1.00136687 |
| 75 | MP0008469_abnormal_protein_level | 0.99774198 |
| 76 | MP0003880_abnormal_central_pattern | 0.96889788 |
| 77 | MP0002429_abnormal_blood_cell | 0.95346769 |
| 78 | MP0002419_abnormal_innate_immunity | 0.94144420 |
| 79 | MP0001243_abnormal_dermal_layer | 0.92205313 |
| 80 | MP0005503_abnormal_tendon_morphology | 0.91594460 |
| 81 | MP0000703_abnormal_thymus_morphology | 0.91540644 |
| 82 | MP0005085_abnormal_gallbladder_physiolo | 0.90519181 |
| 83 | MP0010368_abnormal_lymphatic_system | 0.88810980 |
| 84 | MP0005365_abnormal_bile_salt | 0.85119616 |
| 85 | MP0006276_abnormal_autonomic_nervous | 0.84513999 |
| 86 | MP0004145_abnormal_muscle_electrophysio | 0.83299852 |
| 87 | MP0006082_CNS_inflammation | 0.82650529 |
| 88 | MP0005332_abnormal_amino_acid | 0.81320217 |
| 89 | MP0008058_abnormal_DNA_repair | 0.80172855 |
| 90 | MP0001765_abnormal_ion_homeostasis | 0.79987208 |
| 91 | MP0008995_early_reproductive_senescence | 0.79149051 |
| 92 | MP0005636_abnormal_mineral_homeostasis | 0.77789583 |
| 93 | MP0002019_abnormal_tumor_incidence | 0.76973304 |
| 94 | MP0001119_abnormal_female_reproductive | 0.76080852 |
| 95 | MP0009763_increased_sensitivity_to | 0.74798668 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.74462818 |
| 97 | MP0009643_abnormal_urine_homeostasis | 0.74448140 |
| 98 | MP0003279_aneurysm | 0.73950929 |
| 99 | MP0008775_abnormal_heart_ventricle | 0.73849351 |
| 100 | MP0002234_abnormal_pharynx_morphology | 0.73333071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgG deficiency (HP:0004315) | 4.64826116 |
| 2 | Aplastic anemia (HP:0001915) | 4.46839460 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.90833997 |
| 4 | Hypoproteinemia (HP:0003075) | 3.65674033 |
| 5 | Mitochondrial inheritance (HP:0001427) | 3.47612122 |
| 6 | Severe combined immunodeficiency (HP:0004430) | 3.45126216 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 3.33350475 |
| 8 | Congenital stationary night blindness (HP:0007642) | 3.33065876 |
| 9 | Abnormality of T cell number (HP:0011839) | 3.30202880 |
| 10 | 3-Methylglutaconic aciduria (HP:0003535) | 3.24302457 |
| 11 | T lymphocytopenia (HP:0005403) | 3.21757543 |
| 12 | Reduced antithrombin III activity (HP:0001976) | 3.14433252 |
| 13 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.10523390 |
| 14 | Abolished electroretinogram (ERG) (HP:0000550) | 3.08896412 |
| 15 | Stomatitis (HP:0010280) | 3.08781518 |
| 16 | Increased CSF lactate (HP:0002490) | 3.04584893 |
| 17 | Hepatocellular necrosis (HP:0001404) | 3.04313191 |
| 18 | Pancreatic cysts (HP:0001737) | 3.03668636 |
| 19 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.99925847 |
| 20 | Type I transferrin isoform profile (HP:0003642) | 2.95345459 |
| 21 | Abnormal protein glycosylation (HP:0012346) | 2.90161405 |
| 22 | Abnormal glycosylation (HP:0012345) | 2.90161405 |
| 23 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.90161405 |
| 24 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.90161405 |
| 25 | Attenuation of retinal blood vessels (HP:0007843) | 2.90072778 |
| 26 | Increased hepatocellular lipid droplets (HP:0006565) | 2.89496281 |
| 27 | Abnormality of the prostate (HP:0008775) | 2.88335795 |
| 28 | Acute encephalopathy (HP:0006846) | 2.75002172 |
| 29 | Progressive macrocephaly (HP:0004481) | 2.72723877 |
| 30 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.67983060 |
| 31 | Hepatic necrosis (HP:0002605) | 2.67511122 |
| 32 | Increased IgM level (HP:0003496) | 2.66676609 |
| 33 | Abnormality of B cell number (HP:0010975) | 2.66630340 |
| 34 | Pancytopenia (HP:0001876) | 2.60394623 |
| 35 | Renal Fanconi syndrome (HP:0001994) | 2.59171272 |
| 36 | Pancreatic fibrosis (HP:0100732) | 2.55142673 |
| 37 | Lipid accumulation in hepatocytes (HP:0006561) | 2.54655913 |
| 38 | True hermaphroditism (HP:0010459) | 2.54413418 |
| 39 | Type II lissencephaly (HP:0007260) | 2.52302160 |
| 40 | Thyroiditis (HP:0100646) | 2.51787095 |
| 41 | Exertional dyspnea (HP:0002875) | 2.51675791 |
| 42 | Increased corneal curvature (HP:0100692) | 2.51389330 |
| 43 | Keratoconus (HP:0000563) | 2.51389330 |
| 44 | Combined immunodeficiency (HP:0005387) | 2.50722270 |
| 45 | Optic disc pallor (HP:0000543) | 2.47830778 |
| 46 | Abnormality of the renal cortex (HP:0011035) | 2.43324542 |
| 47 | Prostate neoplasm (HP:0100787) | 2.43251069 |
| 48 | Abnormality of T cells (HP:0002843) | 2.43018360 |
| 49 | Autoimmune hemolytic anemia (HP:0001890) | 2.40143748 |
| 50 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.36576039 |
| 51 | Increased intramyocellular lipid droplets (HP:0012240) | 2.33560389 |
| 52 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.32177473 |
| 53 | Decreased central vision (HP:0007663) | 2.31689327 |
| 54 | Molar tooth sign on MRI (HP:0002419) | 2.31189996 |
| 55 | Abnormality of midbrain morphology (HP:0002418) | 2.31189996 |
| 56 | Hypoplasia of the uterus (HP:0000013) | 2.30930353 |
| 57 | Increased serum lactate (HP:0002151) | 2.30710845 |
| 58 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.29111846 |
| 59 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.29111846 |
| 60 | Renal cortical cysts (HP:0000803) | 2.28250151 |
| 61 | Nephronophthisis (HP:0000090) | 2.27472271 |
| 62 | Stomach cancer (HP:0012126) | 2.26074764 |
| 63 | Methylmalonic acidemia (HP:0002912) | 2.22357178 |
| 64 | Lactic acidosis (HP:0003128) | 2.18795090 |
| 65 | Abnormality of eosinophils (HP:0001879) | 2.18553856 |
| 66 | Retinal dysplasia (HP:0007973) | 2.18521883 |
| 67 | Neonatal respiratory distress (HP:0002643) | 2.16786363 |
| 68 | Abnormal drinking behavior (HP:0030082) | 2.15187763 |
| 69 | Polydipsia (HP:0001959) | 2.15187763 |
| 70 | B lymphocytopenia (HP:0010976) | 2.14072618 |
| 71 | Abnormality of macular pigmentation (HP:0008002) | 2.12577856 |
| 72 | Cerebral edema (HP:0002181) | 2.12561467 |
| 73 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.06323724 |
| 74 | Chronic diarrhea (HP:0002028) | 2.05326029 |
| 75 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.02121395 |
| 76 | Lethargy (HP:0001254) | 1.98197053 |
| 77 | Constricted visual fields (HP:0001133) | 1.98065836 |
| 78 | Pustule (HP:0200039) | 1.95859509 |
| 79 | Methylmalonic aciduria (HP:0012120) | 1.95348272 |
| 80 | Abnormality of the renal medulla (HP:0100957) | 1.93473071 |
| 81 | Dyschromatopsia (HP:0007641) | 1.88252458 |
| 82 | Congenital, generalized hypertrichosis (HP:0004540) | 1.86972463 |
| 83 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.86326894 |
| 84 | Dicarboxylic aciduria (HP:0003215) | 1.86326894 |
| 85 | Oral leukoplakia (HP:0002745) | 1.85556992 |
| 86 | Myositis (HP:0100614) | 1.85357071 |
| 87 | Polyuria (HP:0000103) | 1.83858693 |
| 88 | Abnormal albumin level (HP:0012116) | 1.83595437 |
| 89 | Hypoalbuminemia (HP:0003073) | 1.83595437 |
| 90 | Abnormality of the pons (HP:0007361) | 1.82613913 |
| 91 | Glycosuria (HP:0003076) | 1.82012887 |
| 92 | Abnormality of urine glucose concentration (HP:0011016) | 1.82012887 |
| 93 | Increased muscle lipid content (HP:0009058) | 1.81908227 |
| 94 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.80446717 |
| 95 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.80329467 |
| 96 | Medial flaring of the eyebrow (HP:0010747) | 1.78196768 |
| 97 | Respiratory failure (HP:0002878) | 1.77317156 |
| 98 | Abnormal number of erythroid precursors (HP:0012131) | 1.76425567 |
| 99 | Abnormality of T cell physiology (HP:0011840) | 1.75156290 |
| 100 | Tubular atrophy (HP:0000092) | 1.74349538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K2 | 3.93134343 |
| 2 | TXK | 3.65923352 |
| 3 | VRK2 | 3.60481411 |
| 4 | KDR | 3.25790825 |
| 5 | TESK2 | 3.23512486 |
| 6 | NUAK1 | 3.04629404 |
| 7 | TLK1 | 2.74530781 |
| 8 | BCKDK | 2.69945218 |
| 9 | ZAK | 2.45954243 |
| 10 | TAOK3 | 2.30557672 |
| 11 | SCYL2 | 2.27276781 |
| 12 | ADRBK2 | 2.22675886 |
| 13 | LIMK1 | 1.91139765 |
| 14 | GRK6 | 1.87839110 |
| 15 | CDK19 | 1.82306654 |
| 16 | MAP3K12 | 1.75195198 |
| 17 | TESK1 | 1.72790170 |
| 18 | PINK1 | 1.69851593 |
| 19 | VRK1 | 1.69351850 |
| 20 | MYLK | 1.67132582 |
| 21 | MUSK | 1.66337006 |
| 22 | TEC | 1.61202946 |
| 23 | GRK1 | 1.59459615 |
| 24 | MST4 | 1.53687370 |
| 25 | FLT3 | 1.50077637 |
| 26 | DAPK1 | 1.47973028 |
| 27 | KIT | 1.41086202 |
| 28 | ZAP70 | 1.40941470 |
| 29 | ITK | 1.30837559 |
| 30 | STK16 | 1.28444435 |
| 31 | MAP4K1 | 1.25342432 |
| 32 | EIF2AK3 | 1.23964665 |
| 33 | FRK | 1.12217971 |
| 34 | IKBKE | 1.11535972 |
| 35 | SYK | 1.09177465 |
| 36 | BUB1 | 1.05391622 |
| 37 | DAPK2 | 1.03066032 |
| 38 | BMPR2 | 1.01193502 |
| 39 | TRIM28 | 1.00382866 |
| 40 | IKBKB | 0.99939063 |
| 41 | ERBB3 | 0.98894549 |
| 42 | BTK | 0.98172368 |
| 43 | MAPKAPK3 | 0.95713714 |
| 44 | TBK1 | 0.86191134 |
| 45 | FES | 0.84015200 |
| 46 | TIE1 | 0.82913490 |
| 47 | RPS6KA5 | 0.79123352 |
| 48 | CAMKK2 | 0.78851661 |
| 49 | PASK | 0.78699552 |
| 50 | PRKCQ | 0.76903785 |
| 51 | ACVR1B | 0.75825526 |
| 52 | ADRBK1 | 0.74673862 |
| 53 | LCK | 0.73383349 |
| 54 | JAK3 | 0.72358419 |
| 55 | TAF1 | 0.66838662 |
| 56 | WNK4 | 0.64594880 |
| 57 | INSRR | 0.61358589 |
| 58 | OXSR1 | 0.61252438 |
| 59 | CSNK1G3 | 0.60124687 |
| 60 | DAPK3 | 0.58425032 |
| 61 | PIM2 | 0.57501560 |
| 62 | LYN | 0.57332817 |
| 63 | MAPKAPK5 | 0.57113574 |
| 64 | BMPR1B | 0.57037628 |
| 65 | SRPK1 | 0.57037261 |
| 66 | NME1 | 0.56832075 |
| 67 | MAP3K14 | 0.55876394 |
| 68 | GRK7 | 0.52447797 |
| 69 | IGF1R | 0.52119404 |
| 70 | EIF2AK2 | 0.51673869 |
| 71 | WNK3 | 0.49835324 |
| 72 | GRK5 | 0.49826500 |
| 73 | ROCK1 | 0.49486035 |
| 74 | CSNK1G2 | 0.46967811 |
| 75 | ILK | 0.44860533 |
| 76 | HCK | 0.44502004 |
| 77 | BCR | 0.44237530 |
| 78 | CSF1R | 0.44106186 |
| 79 | RPS6KA4 | 0.43906155 |
| 80 | CSNK1G1 | 0.42649232 |
| 81 | CLK1 | 0.41608523 |
| 82 | MAP2K2 | 0.41321380 |
| 83 | MAP2K6 | 0.40670298 |
| 84 | MATK | 0.37965053 |
| 85 | PHKG1 | 0.36162558 |
| 86 | PHKG2 | 0.36162558 |
| 87 | ABL1 | 0.35934241 |
| 88 | PRKCE | 0.35507068 |
| 89 | JAK1 | 0.34309816 |
| 90 | CSNK1A1L | 0.33576355 |
| 91 | TRPM7 | 0.32363282 |
| 92 | CDK8 | 0.31435553 |
| 93 | STK10 | 0.31246538 |
| 94 | PRKCA | 0.30069119 |
| 95 | MAPK13 | 0.27957113 |
| 96 | PLK3 | 0.27952811 |
| 97 | PIM1 | 0.27749941 |
| 98 | PTK2B | 0.27017185 |
| 99 | INSR | 0.26413606 |
| 100 | PIK3CG | 0.26145834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.54316409 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.76839483 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.81253152 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.57256511 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.52237110 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.50669767 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.48165098 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.48040225 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.34826429 |
| 10 | Ribosome_Homo sapiens_hsa03010 | 2.27962604 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.20336055 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.09766055 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.02611154 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.97924631 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.91084150 |
| 16 | Protein export_Homo sapiens_hsa03060 | 1.88533821 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.85194846 |
| 18 | Phototransduction_Homo sapiens_hsa04744 | 1.73198835 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.67190909 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.56076749 |
| 21 | Homologous recombination_Homo sapiens_hsa03440 | 1.53586471 |
| 22 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.49523618 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41140004 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.34668778 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.33764165 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.26500686 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25790385 |
| 28 | Basal transcription factors_Homo sapiens_hsa03022 | 1.25037473 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19270224 |
| 30 | Base excision repair_Homo sapiens_hsa03410 | 1.18298319 |
| 31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.15788784 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.14441420 |
| 33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.13378028 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12546516 |
| 35 | RNA degradation_Homo sapiens_hsa03018 | 1.12497652 |
| 36 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.12494726 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.10776540 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.09484227 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08605012 |
| 40 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.08107842 |
| 41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.07315915 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01802250 |
| 43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.00588921 |
| 44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98895896 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.97059575 |
| 46 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.95737628 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95089637 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.90288516 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.89020080 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.87781391 |
| 51 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.87646379 |
| 52 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.86031330 |
| 53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.85930433 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85359336 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.81930384 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78626478 |
| 57 | Olfactory transduction_Homo sapiens_hsa04740 | 0.78043988 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76779506 |
| 59 | Purine metabolism_Homo sapiens_hsa00230 | 0.76375647 |
| 60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75716330 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.75333186 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75324746 |
| 63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74811348 |
| 64 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73056195 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.72105423 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71459818 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71315119 |
| 68 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.69478534 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69315198 |
| 70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.65768175 |
| 71 | Spliceosome_Homo sapiens_hsa03040 | 0.65225281 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60955766 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58505515 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56413850 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56074974 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52519831 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52255216 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52015931 |
| 79 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51466771 |
| 80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.51302220 |
| 81 | Measles_Homo sapiens_hsa05162 | 0.50144957 |
| 82 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.47292808 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.46970584 |
| 84 | Mismatch repair_Homo sapiens_hsa03430 | 0.45610198 |
| 85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.43355434 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43078701 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.42030226 |
| 88 | RNA transport_Homo sapiens_hsa03013 | 0.41929743 |
| 89 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.41404614 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.39954450 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.38187233 |
| 92 | DNA replication_Homo sapiens_hsa03030 | 0.35351158 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.34847150 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.34262990 |
| 95 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.33465827 |
| 96 | Taste transduction_Homo sapiens_hsa04742 | 0.31490902 |
| 97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24051309 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.23055147 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.22186443 |
| 100 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.21131085 |

